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Rheumatoid arthritis (RA) is an inflammatory autoimmune disorder of unknown etiology which affects multiple joints 
and causes cartilage erosion. Due to the side effects associated with the conventional treatment strategies, alternate medicine 
using plant extracts is on the rise for the treatment of arthritic conditions. In the present study, we evaluated the anti-arthritic 
potential of two phytocompounds from Alpinia calcarata (Haw.) Roscoe, a potential medicinal herb, locally called ‘Kolinji’, 
used in traditional medicine. The selected compounds, fenchol and 2,4-di-tert-butylphenol, were evaluated for their efficacy 
in Freund’s complete adjuvant induced arthritis in rats. Arthritis assessment was done by measuring the paw volume, paw 
size, arthritic score and body weight. Various hematological and biochemical parameters were assessed on the last day of the 
study. Histological and radiological analysis of the ankle joints was done. The compounds treated at both doses (50 and 
100 mg/kg body wt.) showed a dose dependent decrease in paw volume, paw size and arthritic score following arthritis 
induction. Treatment with the standard drug (diclofenac) and phytocompounds were followed by favourable outcome in the 
altered hematological parameters and the level of liver enzymes. The radiological and histological analysis also confirmed 
the anti-arthritic potential of these compounds. The results revealed the potential of the plant for use in the therapeutic 
management of rheumatoid arthritis.  
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Rheumatoid arthritis (RA) is a systemic autoimmune 
disease, characterized by the inflammation of 
synovium leading to destruction of bones and 
cartilage in various joints1. It is two to three times 
more frequent in women than in men and can start at 
any age, with a peak incidence between the fourth and 
sixth decade of life. Apart from the conventional 
treatment strategies using nonsteroidal anti-
inflammatory drugs, disease modifying antirheumatic 
drugs and glucocorticoids, newer and safer drugs are 
continuously being searched, as long term usage of 
these drugs have resulted in adverse effects. 
Alternative medicine provides another approach for 
treatment of RA and currently a number of medicinal 
plants are under scientific evaluation to develop a 
novel drug. Various clinical and preclinical studies 
have reported the mechanism of action of herbal 
extracts and the role of phytoconstituents, such as 
flavonoids, terpenoids, alkaloids and sterols in 
attenuating the symptoms of RA by targeting the 
inflammatory biomarkers involved in the 
pathogenesis of RA2. 
The selected plant Alpinia calcarata (Haw.) 
Roscoe (Fam. Zingiberaceae), commonly called Snap 
ginger or Lesser galangal, and locally, Kolinji, is a 
rhizomatous perennial herb commonly used in the 
traditional medicinal systems and is cultivated in 
tropical countries including China, India, Srilanka and 
Malaysia. The rhizomes, the most important part of 
the plant, is known to possess a broad spectrum of 
medicinal and pharmacological properties. Decoction 
of the rhizomes is widely used in the treatment of 
bronchitis, cough, respiratory ailments, diabetes, 
asthma and arthritis3. Phytochemical analysis of the 
rhizomes has revealed the presence of major 
phytoconstituents such as polyphenols, tannins, 
flavonoids, steroid, glycosides and alkaloids4. Major 
phytoconstituents identified from A. calcarata include 
protocatechinic acid, quercetin, 4-O-methyl-syringic 
acid, vanillic acid, methyl cinnamate, 1,8-cineole, 
camphor, α-terpineol, β-pinene, α-pinene, camphene, 
endo-fenchyl acetate, etc5.The anti-inflammatory 
activity of A. calcarata validated by the carrageenan-
induced paw oedema model in rats concluded that 
inhibition of histamine and prostaglandin synthesis 
production was the probable mechanisms by which it 
mediates its anti-inflammatory action6. 
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Here, we selected two compounds, fenchol and 2,4-
di-tert-butylphenol, from Alpinia calcarata  
for studying its antiarthritic potential using  
adjuvant induced arthritis model. Fenchol (2,2,4-
trimethylbicyclo[2.2.1]heptan-3-ol) is a bicyclic 
monoterpenoid reported from various species of 
aromatic plants and is a commonly used volatile 
compound in fragrances and flavouring agents7;  
and 2,4-di-tert-butylphenol is a bioactive compound 
identified from several medicinal plants and  
lower organisms8 that has been reported to possess 
various bioactivities including antioxidant9, 
antifungal10, antibacterial11, herbicidal12 and 
antibiofilm13 activities. 
 
Materials and Methods 
 
Chemicals 
Fenchol, 2,4-di-tert-butylphenol and diclofenac 
sodium were purchased from Sigma Aldrich (USA). 
Freund’s complete adjuvant was obtained from 
Chondrex (WA). All other chemicals used were of 
highest quality available. 
 
Experimental animals 
Sprague Dawley (SD) rats (180-240 g) of both 
sexes obtained from the Small Animal Breeding 
Station, College of Veterinary and Animal Sciences, 
Thrissur were maintained in the animal house of 
Department of Biotechnology and Microbiology, 
Kannur University. The animals were maintained 
under standard environmental conditions with 12-h 
dark/light cycles and were fed with standard pellet 
diet (Krish Scientists Shoppe) and water ad libitum. 
The experimental protocols were approved by the 
Institutional Animal Ethics Committee (KULS/IAEC/ 
2013/08) and the guidelines of CPCSEA, Govt. of 
India were followed for the care and maintenance of 
animals.  
 
Induction of Arthritis and treatment protocol  
Animals were divided into 7 groups of 6 animals as 
follows: Gr. I, Normal rats; Gr. II, FCA induced 
arthritic rats; Gr.oup III, FCA + diclofenac (10 mg/kg 
body wt.); Gr. IV & V, FCA + DTBP (50 and  
100 mg/kg body wt.); Gr. VI & VII, FCA + fenchol 
(50 and 100 mg/kg body wt.), respectively. Arthritis 
was induced by a single intradermal injection of  
0.1 mL of Freund’s complete adjuvant (10 mg/mL) 
into the plantar surface of the left hind paw of the 
animal under light ether anesthesia. The dosing of all 
the groups was started from day 9th once daily through 
oral route and the study was continued till day 24. 
Diclofenac (10 mg/kg bodywt.) was used as the 
standard drug in the study. The severity of arthritis 
was evaluated by the changes in in paw size using 
digital vernier calipers on the 3rd, 6th, 9th, 12th, 15th, 
18th and 21st day after arthritis induction14. During the 
experimental period, the body weight was measured 
using a digital weighing balance every 3rd day after 
adjuvant injection. The mean changes in injected paw 
with respect to initial paw volume, were calculated on 
respective days and percentage inhibition of paw 
edema with respect to untreated group (control) was 
calculated using the formula:  
 𝑃𝑒𝑟𝑐𝑒𝑛𝑡𝑎𝑔𝑒 𝑖𝑛ℎ𝑖𝑏𝑖𝑡𝑖𝑜𝑛 =  1 −  𝑀𝑒𝑎𝑛 𝑐ℎ𝑎𝑛𝑔𝑒𝑠 𝑖𝑛 𝑝𝑎𝑤 𝑣𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑡𝑟𝑒𝑎𝑡𝑒𝑑 𝑟𝑎𝑡𝑀𝑒𝑎𝑛 𝑐ℎ𝑎𝑛𝑔𝑒𝑠 𝑖𝑛 𝑝𝑎𝑤 𝑣𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑢𝑛𝑡𝑟𝑒𝑎𝑡𝑒𝑑 𝑟𝑎𝑡 𝑋 100 
 
On day 25th, the animals were euthanized and 
blood was collected for hematological and 
biochemical evaluation. Organs such as thymus 
spleen and liver were removed to determine the wet 
weight of organs. Ankle joints were separated for 
histological analysis  
 
Visual arthritis scoring system  
The morphological feature of the arthritis like 
swelling and erythema15 was monitored by set of 
visual criteria as follows: normal paw = 0, mild 
swelling and erythema of digits = 1, swelling and 
erythema of the digits = 2, severe swelling and 
erythema = 3, gross deformity and inability to use the 
limb = 4 on respective days. Thus, the maximum 
possible score for both hind paws was 816. 
 
Hematological and biochemical analysis 
RBC, WBC, Hemoglobin, ESR and platelet count 
were estimated using Horiba 5 part Hematology 
analyser. serum glutamic pyruvic transaminase 
(SGPT), serum glutamic oxaloacetic transaminase 
(SGOT) and alkaline phosphatase (ALP), Total 
proteins (TP) and C- reactive protein (CRP) were 
determined using standard diagnostic kits (Proton, 
Accurex) and analysed using Statfax autoanalyser. 
 
Organ index 
At the end of the experiment, rats were euthanized 
and liver spleen and thymus were promptly removed 
and weighed. The index of the organs was expressed 
as the percentage (%) wet weight of organ versus 
body weight17. The organ indexes were calculated 
using the following formula  
 
 𝑂𝑟𝑔𝑎𝑛 𝑖𝑛𝑑𝑒𝑥 = 𝑊𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑜𝑟𝑔𝑎𝑛 𝑔𝐵𝑜𝑑𝑦 𝑤𝑒𝑖𝑔ℎ𝑡 𝑔  𝑋 100 
 
Radiological analysis 
Radiographic changes in RA conditions are useful 
diagnostic measures which indicate the severity of the 




disease. Soft tissue swelling is the earlier radiographic 
sign, whereas prominent radiographic changes like bony 
erosions and narrowing of joint spaces can be observed 
only in the developed stages (final stages) of arthritis18. 
X ray radiographs the hind paw of rats in each groups 
were taken using conventional X ray machine on day 24 
and examined for radiological changes. 
 
Histological analysis 
Ankle joints were separated from the hind paw, 
weighed and immersed in 10% buffered formalin for 
24 h followed by decalcification in 5% Nitric acid, 
processed for paraffin embedding and sectioned at  
3-5 µM thickness. The sections were stained with 
haematoxylin and eosin and evaluated under light 
microscope for the presence of hyperplasia of 




All values were expressed as mean ± SEM (𝑛 = 6). 
Statistical analysis was performed using one-way 
analysis of variance (ANOVA) followed by Post Hoc 
Tukey HSD using SPSS software version 20. A P value 




Effect of 2,4-DTBP and Fenchol on paw edema in FCA 
induced arthritis 
Intraplantar injection of FCA rapidly produced 
typical inflammatory swelling and redness in the 
injected left hind paw from day 1 which reached a 
peak on day 9. In arthritic control group, the paw 
swelling was maintained throughout the experimental 
period with gross deformity of the injected limb by 
day 24. The paw thickness of the injected paw were 
measured every 3rd day following FCA injection. The 
percentage inhibition of paw edema was calculated in 
each case and tabulated. Treatment with the standard 
drug Diclofenac showed a significant decrease in the 
edema from day 12 onwards when compared to 
control (P <0.05). Treatment with the compounds, 
DTBP and Fenchol, suppressed paw edema in a dose 
dependent manner. Treatment with the compounds at 
both doses exhibited a significant reduction in paw 
swelling when compared to control on day 24 (P <0.05) 
which was indicated by a decrease in the paw 
thickness measured (Fig. 1A). 
 
Effect of 2,4-DTBP and Fenchol on arthritic score in FCA 
induced arthritis 
All the groups of rat injected with FCA started 
showing signs of clinical inflammation indicated by 
swelling and redness of the left hind paw. The 
arthritic score was significantly increased from day 6 
to 12 in arthritic control group which remained 
increased throughout the period of the study. Rats 
treated with Diclofenac showed significant decrease 
in arthritic score from day 12 till day 24. The arthritic 
score of the phytocompounds treated group showed a 
dose dependent decrease following treatment in a 
statistically significant manner when compared to 
control (Fig. 1B and Fig. 2). 
 
Effect of 2,4-DTBP and Fenchol on body weight in FCA 
induced arthritis 
The body weight of rats in all groups were 
monitored every 3rd day after adjuvant induction till 
the end of the experiment. It was observed that the 
normal rats gained weight progressively until the end 
 
Fig. 1 — Effect of DTBP and Fenchol on (A) paw thickness; (B) arthritic score; and (C) body weight in FCA induced arthritis. [Values 
are expressed as mean ± SEM (n=6). a normal vs. other groups, b FCA versus other treatment groups. Symbols represent statistical 
significance *(P <0.05), #(P <0.001)] 




of the experimental period (24 days). Adjuvant 
arthritic rats also gained weight until the 10th day,  
but at lower rates than those of normal rats. After the 
10th day, a gradual decrease was observed, so that  
the mean body weight did not differ significantly 
from the initial weight by day 24. The average gain  
in the body weight on day 24 as compared with the 
initial body weight in each group has been tabulated. 
Rats treated with Diclofenac showed a statistical 
significant increase in body weight gain (P <0.05) 
when compared to FCA group. Treatment with  
the phytocompounds showed a slight increase in  
body weight gain when compared to the arthritic 
group which was not much statistically significant 
(Fig. 1C). 
 
Effect of 2,4-DTBP and Fenchol on hematological and 
biochemical parameters 
There was a significant reduction in RBC count 
and haemoglobin in arthritic group when compared 
to normal (P <0.001). A significant increase in 
WBC count, ESR and platelet count was also 
observed in FCA group compared to normal group 
(P <0.05). Treatment with the standard drug  
and phytocompounds were followed by favorable 
outcome in the altered hematological parameters. 
The levels of liver enzymes serum glutamic pyruvic 
transaminase (SGPT), serum glutamic oxaloacetic 
transaminase (SGOT) and alkaline phosphatase 
(ALP) was found to be elevated in FCA induced 
arthritic groups compared to normal rats. Treatment 
with diclofenac and phytocompounds at both  
doses (50 and 100 mg/kg) could significantly 
decrease the level of these enzymes indicating a 
beneficial effect. The elevated CRP level following 
arthritis induction was significantly reduced by 
treatment with diclofenac as well as phytocompounds 
(Tables 1 and 2). 
 
Effect of 2, 4-DTBP and Fenchol on organ index in FCA 
induced arthritis 
FCA induced arthritic group showed a significant 
increase in liver index when compared to normal rats 
(P <0.05). Treatment with Diclofenac, DTBP (50 
mg/kg) and Fenchol (100 mg/kg) was accompanied 
by a significant decrease (P <0.05) in the liver index 
showing a beneficial effect. A slight increase in the 
weight of spleen was observed in FCA group 
compared to normal group, whereas no signification 
reduction of spleen index was observed in all 
treatment groups. The thymus index of the FCA group 
did not show any statistically significant change when 
compared to normal group or any other treatment 
groups (Table 3). 
 
Radiological analysis 
The radiographs of normal rats exhibited normal 
bone and cartilage morphology with no signs of soft 
tissue swelling, whereas those of the arthritis group 
 
Fig. 2 — Effect of DTBP and Fenchol on the extent of paw swelling in FCA induced arthritis. (A) normal; (B) FCA group; (C)
Diclofenac treated group; (D & E) DTBP (50 and 100 mg/kg) treated group; and (F & G) Fenchol (50 and 100 mg/kg) treated group 
 




presented with joint degradation, narrowing of joint 
spaces and soft tissue swelling. Diclofenac treatment 
effectively reduced the extent of pathological features 
of arthritis evident from the radiographs. Treatment 
with compounds also showed a dose dependent 
reduction in bone erosion and soft tissue swelling, 
suggesting a beneficial role in treatment (Fig. 3). 
 
Histological analysis  
Histological analysis of the control group showed 
normal joint architecture and cell structure. The joint 
architecture was markedly abnormal in arthritic rats 
with massive infiltration of polymorphic neutrophils 
into the edematous synovium and joint cavity. Additional 
findings such as pannus formation, bone erosion, 
synovial hyperplasia were also evident. Treatment 
with Diclofenac significantly supressed the infiltration 
of inflammatory cells in synovial membrane and joint 
cavity. The rats treated with the phytocompounds 
showed significantly reduced pathological changes in 
a dose dependent manner compared to arthritic rats. 
Higher doses of the compounds showed a protective 
effect on the joint structure with marked reduction of 
articular cartilage destruction, bone erosion and 
inflammatory cell infiltration (Fig. 4). 
 
Discussion 
The use of animal models of RA has contributed 
greatly to the overall knowledge of processes/ 
mediators important in the generation of 
inflammation, cartilage destruction and bone 
resorption, thus leading to important advances in 
therapeutic intervention in this destructive disease19. 
 
Hind paw swelling is a characteristic feature of 
adjuvant induced arthritis which is monitored from 
day 9 (onset of disease) to 15 or greater depending on 
duration desired20. All rats showed an arthritic score 
>1indicating the incidence of arthritis before the 
initiation of treatment21. Several lines of studies have 
reported the efficacy of paw swelling as an index to 
measure arthritis severity in adjuvant induced arthritis 
model for the preclinical testing of both synthetic and 
herbal extract22,23. The changes in paw edema 
following arthritis induction and treatment analyzed 
by caliper measurements in the present study could 
clearly assess disease progression and remission. 
 
A record of the weight changes which occur in 
treated and control rats during the development of the 
syndrome provides useful supplementary information 
for assessing the activity of the compounds 
examined24. It has been reported that during the 
development of the arthritic syndrome the rats 
Table 1 — Effect of DTBP and Fenchol on hematological parameters in FCA induced arthritis. Values are expressed as mean ± SEM 
(n=6). a normal vs. other groups, bFCA versus other treatment groups. Symbols represent statistical significance *(P <0.05), #(P <0.001) 
Group Hb (g/dL) RBC (×106 cells/mm3) WBC (×10
3 
cells/mm3) ESR (mm/h) Platelet (lakhs/Cumm) 
Normal 13.86±0.20 6.96±0.37 9.23±1.62 4.26±0.40 3.36±1.19 
FCA group 9.566±0.87a# 4.233±0.45a# 13.43±2.07a* 13.51±2.02a# 10.58±1.01a# 
Diclofenac 12.83±0.25a*b* 6.80±0.40b# 9.96±0.57b* 5.28±0.91b# 5.20±1.60a*b# 
DTBP (50 mg/kg ) 10.43±0.70a# 4.80±0.40a# 12.68±2.87a* 9.32±1.64a#b* 10.25±0.83a# 
DTBP (100 mg/kg) 12.58±0.60a*b* 5.70±0.30a*b* 10.06±1.01b* 6.68±1.03a*b# 6.36±0.8.a*b# 
Fenchol (50 mg/kg) 10.266±0.58a# 4.00±0.36a# 11.60±9.84 10.18±0.32a#b* 8.43±0.76a#b* 
Fenchol (100 mg/kg) 12.93±0.25a*b* 6.20±0.30a*b# 9.93±5.13b* 6.39±1.04a*b# 5.63±0.70a*b# 
 
Table 2 — Effect of DTBP and Fenchol on biochemical parameters in FCA induced arthritis. [Values are expressed as mean ± SEM (n=6). a- 
normal versus other groups, b- FCA versus other treatment groups. Symbols represent statistical significance *(P <0.05), # (P <0.001)] 
Group SGOT (IU/L) SGPT (IU/L) ALP (IU/L) Total Proteins (mg/L) CRP (mg/L) 
Normal 94.66±3.75 41.38±1.85 100.66±6.35 5.90±0.05 1.333±0.33 
FCA group 322.66±6.48a# 73.66±4.90a# 394.00±18.19a* 6.86±0.12a# 14.33±1.44a# 
Diclofenac 214.33±22.02a#b# 77.33±2.40a# 178.66±9.24a#b# 6.86±0.08a# 4.33±0.69a*b# 
DTBP (50 mg/kg ) 250.66±4.40a#b* 62.00±5.12a*b* 170.66±12.67a*b# 6.26±0.17b* 9.00±2.07a#b* 
DTBP (100 mg/kg) 141.66±21.16a*b# 54.66±5.68a*b* 132.66±6.17a*b# 6.06±0.25b* 4.66±0.87a*b# 
Fenchol (50 mg/kg) 294.36±8.75a# 65.00±4.61a# 287.33±6.98a#b# 6.4±0.25a*b* 10.33±1.5a#b* 
Fenchol (100 mg/kg) 254.33±10.26a#b* 54.66±0.87a*b* 238.33±15.30a#b# 6.00±0.11b* 7.20±0.57a*b* 
 
Table 3 — Effect of DTBP and Fenchol on organ index in FCA
induced arthritis. [Values are expressed as mean ± SEM (n=6). a
normal versus other groups, b FCA vs. other treatment groups.
Symbols represent statistical significance *(P <0.05), #(P <0.001)] 
Group Organ index (%) Liver Spleen Thymus 
Normal 2.27±0.27 0.15±0.010 0.0260±0.001 
FCA group 2.83±0.015a* 0.1913±0.023 0.018±0.001 
Diclofenac 1.90±0.26b* 0.17±0.027 0.0243±0.007 
DTBP (50 mg/kg ) 2.15±0.085b* 0.19±0.02 0.022±0.007 
DTBP (100 mg/kg) 2.66±0.12 0.18±0.02 0.024±0.008 
Fenchol (50 mg/kg) 2.40±0.065 0.19±0.008 0.027±0.10 
Fenchol (100 mg/kg) 2.11±0.16b* 0.18±0.007 0.025±0.002 
 




invariably lost weight. The heavier the rat at the time 
of injection, the greater was the weight loss in 
absolute terms25. The results of the changes in body 
weight from the present study are consistent with 
these findings26. 
 
The marked decrease in body weight of arthritic 
rats was associated with a marked increase in liver 
and spleen weights, results that coincide with the 
report of Bendele 2001, who stated that splenomegaly 
and hepatomegaly are the main extra-articular 
manifestations in the adjuvant arthritic model. The 
author also stated that the restoration of both organs is 
linked to agents that are active against adjuvant 
arthritis and that possess an anti-arthritic effect18. The 
present study was accompanied by an increase in liver 
weight which was beneficially affected by treatment, 
but no significant difference in the weight of spleen 
was noted in any of the treatment groups27. 
 
Patients with rheumatoid arthritis (RA) may 
present with haematological abnormalities either at 
the time of diagnosis, or during the course of their 
illness28. Anaemia, thrombocytosis and eosinophilia 
are observed commonly whereas neutropenia, 
thrombocytopenia, large granular lymphocytosis 
(LGL) and malignancies are uncommon29. A decrease 
in the level of hemoglobin and RBC, and increase in 
the level of WBC, platelet and ESR were noted in the 
present study in arthritic rats which were reverted 
towards normal in treatment groups30. Elevated liver 
enzymes in patients with rheumatoid arthritis may 
have various causes. These can range from the 
rheumatic disease itself, the anti-rheumatic 
medication or be the manifestation of an associated 
autoimmune disease31. It has been reported that there 
is a relationship between the severity of rheumatoid 
arthritis and the hepatic dysfunction indicated by 
certain liver function tests32. Estimation of CRP level 
is one of the most reliable and objective measure and 
a useful prognostic factor for disease progression  
to joint damage associated with RA33. As an 
inflammatory biomarker for RA, CRP correlates with 
disease activity, histological changes in the synovium, 
and radiological progression, responding very quickly 
to changes in disease activity34. The present study on 
biochemical parameters also confirmed a positive 
correlation between the level of liver enzymes and 
disease severity which were favorably affected by 
treatment. Similar was the results obtained in the case 
of CRP levels. 
 
Radiographic analysis provides useful insights into 
the severity of arthritis by the degree of soft tissue 
swelling bony erosions and narrowing of joint 
spaces35. The major radiographic changed evident in 
the radiographs of present study was soft tissue 
swelling, joint degradation and narrowing of joint 
spaces which was beneficially affected by treatment36. 
The histological sections from the inflamed joints of 
RA patients exhibit infiltration of inflammatory cells 
and hyperplasia, which is responsible for the 
degradation of cartilage and bone37. The histological 
sections of joints from arthritic group were marked by 
the massive infiltration of neutrophils which was 
significantly decreased in treatment groups indicating 
a therapeutic potential of the tested compounds38. 
 
Conclusion 
The results of the present study showed that both 
the selected compounds at the doses tested could 
 
 
Fig. 3 — X-ray radiographs of rat paws. (A) normal; (B) FCA group; (C) Diclofenac treated group; D & E) DTBP (50 and 100 mg/kg)
treated group; and (F & G) Fenchol (50 and 100 mg/kg) treated group 
 
 
Fig. 4 — Histological analysis of joints. (A) normal; (B) FCA group; (C) Diclofenac treated group; D & E) DTBP (50 and 100 mg/kg)
treated group; and (F & G) Fenchol (50 and 100 mg/kg) treated group 
 




significantly affect the reduction in paw edema, 
alterations in hematological and biochemical 
parameters following arthritis induction. The 
significant reduction in the elevated liver enzymes 
following treatment with the compounds indicated 
that the tested compounds were safe in terms of 
hepatotoxicity. Taken together from the results 
presented, it can be concluded that the 
phytocompounds present in Alpinia calcarata possess 
significant anti-arthritic activity which supports the 
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